Padella, Antonella
Ghelli Luserna Di RorĂ , Andrea
Marconi, Giovanni
Ghetti, Martina
Martinelli, Giovanni
Simonetti, Giorgia
Funding for this research was provided by:
Horizon 2020 (ERAPERMED2018-275)
Associazione Italiana Contro le Leucemie - Linfomi e Mieloma (Ail Treviso)
Article History
Received: 15 November 2021
Accepted: 12 January 2022
First Online: 22 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: G.M. has competing interests with Menarini/Stemline Therapeutics, Pfizer, Astellas, Abbvie, Astrazeneca. G.Ma. has competing interests with Ariad/Incyte, Pfizer, Celgene/BMS, Amgen, Roche, AbbVie, GlaxoSmithKline, Astellas, Daiichi Sankyo, Takeda, Gilead, Astellas, Janssen, Novartis, MSD.